Aqueous Extract of Rhubarb Promotes Hepatotoxicity via Facilitating PKM2-Mediated Aerobic Glycolysis in a Rat Model of Diethylnitrosamine-Induced Liver Cancer
Anni Zhao,Xiaomei Liu,Xiping Chen,Sha Na,Hui Wang,Xuan Peng,Peizhong Kong,Lu Li
DOI: https://doi.org/10.2147/dddt.s476273
IF: 4.3188
2024-10-10
Drug Design Development and Therapy
Abstract:Anni Zhao, 1, &ast Xiaomei Liu, 1, &ast Xiping Chen, 1, &ast Sha Na, 1, &ast Hui Wang, 1 Xuan Peng, 1 Peizhong Kong, 1 Lu Li 1, 2 1 Department of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012, People's Republic of China; 2 Institute of Integrated Chinese and Western Medicine, Anhui Academy of Chinese Medicine, Hefei, 230012, People's Republic of China &astThese authors contributed equally to this work Correspondence: Peizhong Kong; Lu Li, Department of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, No. 350, Longzihu Road, Xinzhan District, Hefei, Anhui, People's Republic of China, Email ; Objective: To identify the polar parts in Rhubarb that cause hepatotoxicity and explore the underlying mechanisms. Methods: The rat model of liver cancer was established by gavage of diethylnitrosamine (DEN; 0.002 g/rat) for 14 weeks. Starting from the 11th week, Rhubarb granule (4 g/kg), aqueous, ethyl acetate and n-butanol extract of Rhubarb or Rhein equivalent to a dose of 4 g/kg Rhubarb granule were administered intragastrically for 4 consecutive weeks. Liver tissues from rats treated with DEN and Rhubarb granules were used for non-targeted metabolomics analysis. The correlation between pyruvate kinase isozyme type M2 (PKM2) expression level and the progress and prognosis of hepatocellular carcinoma (HCC) was evaluated through bioinformatics analysis based on TCGA database. Liver tissues and blood samples from rats treated with DEN and aqueous, ethyl acetate and n-butanol extract of Rhubarb were used for the screening of hepatotoxic polar parts of Rhubarb. The liver injuries were evaluated by the changes in pathology, liver function, and the expression levels of proliferating cell nuclear antigen (PCNA) and transforming growth factor beta1 (TGF-β 1). The mechanism studies focus on PKM2 expression, and the metabolic reprogramming via detecting the activities of lactate dehydrogenase A (LDHA) and isocitrate dehydrogenase (ICDH). Furthermore, molecular docking analysis was performed to validate the target interaction between Rhein and PKM2, and the hepatotoxicity of Rhein was evaluated by testing liver function in the DEN-induced liver cancer model. Results: The non-targeted metabolomics analysis revealed that Rhubarb promoted aerobic glycolysis in the rat model of DEN-induced liver cancer. And bioinformatics analysis revealed that high PKM2 expression was closely related to the progression and poor prognosis of HCC. In vivo studies indicated that the aqueous extract of Rhubarb, but not ethyl acetate and n-butanol extract, promoted the liver injuries induced by DEN. The mechanism study showed that the aqueous extract of Rhubarb increased the expression of PKM2 and promoted aerobic glycolysis. Moreover, Rhein had a strong binding affinity for PKM2 and aggravated liver injury in the DEN-induced liver cancer model. Conclusion: Aqueous extract of Rhubarb promoted hepatotoxicity via facilitating PKM2-mediated aerobic glycolysis in the rat model of DEN-induced liver cancer. Keywords: aqueous extract of rhubarb, hepatotoxicity, PKM2, aerobic glycolysis, Rhein Graphical Rheum palmatum L. (Rhubarb, Dahuang), a traditional Chinese herbal medicine, belongs to the Polygonaceae family, and is usually used to treat constipation, damp-heat dysentery, gastrointestinal bleeding, and other diseases. 1,2 Rhubarb was first recorded in the classic Materia Medica, Shen Nong Ben Cao Jing , 3 and has been recorded in the Chinese Pharmacopoeia. 4 Recently, numerous studies showed that Rhubarb, especially the free anthraquinone components, could alleviate various types of liver diseases, such as hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). 5–8 Nevertheless, the safety of Rhubarb in the treatment of liver diseases is still controversial. The toxic effects of Rhubarb on liver have been verified in vitro and in vivo. 9,10 The hepatotoxicity of Rhubarb was affected by diverse factors, such as the dosage and duration of administration, dosage form, processing method, and compatibility of formula. Rhubarb causes hepatotoxicity in a dose-dependent manner within a certain range. 11,12 The routine daily dosage of Rhubarb in the 2015 Chinese Pharmacopoeia is 3–15 g, and the clinical usual dosage is 10 g. However, excessive use of Rhubarb frequently occurs in clinical treatment of liver diseases. -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal